CARDIAC RISK STRATIFICATION

• US 20110082378A1
• Filed: 04/22/2010
• Published: 04/07/2011
• Est. Priority Date: 10/06/2009
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Messier, Marc D., Becker, Daniel, Schneider, Raphael
• Granted Patent: US 8,380,294 B2
• Time in Patent Office: Days
• US Class Current: 600/509
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/0205 Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
• CPC Class Codes: A61B 5/316 Modalities, i.e. specific diagnostic methods
• CPC Class Codes: A61B 5/335 using integrated circuit memory devices
• CPC Class Codes: A61B 5/346 Analysis of electrocardiograms
• CPC Class Codes: A61B 5/7275 Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

This disclosure describes techniques for generating a risk stratification indicator based on HRT measurements computed using physiological parameters sensed by an implantable medical device (IMD). In some examples, the HRT measurements may be computed by the IMD based on the physiological parameters. In other examples, the IMD may sense the physiological parameters, and transmit data representative of the parameters to an external computing device, such as an IMD programmer, which then computes the HRT measurements. Exemplary physiological parameters include cardiac signals.

Claims

1. A method comprising:

determining, from physiological parameters of a patient, a first heart rate turbulence (HRT) slope at a first time and a second HRT slope at a second time;

calculating a difference value between the first slope and the second slope; and

determining a level of recovery of autonomic function based on the calculated difference.

2. The method of claim 1, wherein the first time is approximately one week after the occurrence of a myocardial infarction, and wherein the second time is approximately six weeks after the occurrence of a myocardial infarction.

3. The method of claim 1, further comprising:

comparing the difference value to a threshold value of about 2 milliseconds per R-R interval, wherein determining a level of recovery comprises determining the level of recovery based on the comparison.

4. The method of claim 3, wherein determining the level of recovery of autonomic function based on the calculation comprises:

determining the level of recovery to be in a first category if the difference value is equal to or greater than the threshold value; and

determining the level of recovery to be in a second category if the difference value is less than the threshold value.

5. The method of claim 4, further comprising:

generating a risk stratification indicator if the level of recovery is determined to be in the second category.

6. The method of claim 5, wherein the risk stratification indicator indicates at least one of that the patient should be hospitalized, that the patient should be fitted with an implantable therapy device configured to deliver therapy, and that therapy delivered to the patient should be modified.

7. The method of claim 1, further comprising:

delivering, when no intrinsic abnormal heartbeats are occurring, electrical stimulation at a first time in order to induce a plurality of abnormal heartbeats at the first time; and

delivering, when no intrinsic abnormal heartbeats are occurring, electrical stimulation at a second time in order to induce abnormal heartbeats at the second time,

wherein determining, from physiological parameters of a patient, a first heart rate turbulence (HRT) slope at a first time and a second HRT slope at a second time comprises determining the first HRT slope from the abnormal heartbeats induced at the first time and determining the second HRT slope from the abnormal heartbeats induced at the second time.

8. An implantable medical device (IMD) comprising:

a measurement unit configured to obtain physiological parameters for a patient; and

a processor configured to;

determine, from the physiological parameters, a first heart rate turbulence (HRT) slope at a first time and a second HRT slope at a second time;

calculate a difference value between the first slope and the second slope; and

determine a level of recovery of autonomic function based on the calculated difference.

9. The IMD of claim 8, wherein the first time is approximately one week after the occurrence of a myocardial infarction, and wherein the second time is approximately six weeks after the occurrence of a myocardial infarction.

10. The IMD of claim 8, wherein the processor is further configured to:

compare the difference value to a threshold value of about 2 milliseconds per R-R interval, and wherein the processor configured to determine a level of recovery is further configured to determine the level of recovery based on the comparison.

11. The IMD of claim 10, wherein the processor configured to determine the level of recovery of autonomic function based on the calculation is further configured to:

determine the level of recovery to be in a first category if the difference value is equal to or greater than the threshold value; and

determine the level of recovery to be in a second category if the difference value is less than the threshold value.

12. The IMD of claim 11, wherein the processor is further configured to:

generate a risk stratification indicator if the level of recovery is determined to be in the second category.

13. The IMD of claim 12, further comprising:

transmitting the risk stratification indicator from the IMD to another device.

14. The IMD of claim 13, wherein the risk stratification indicator indicates at least one of that the patient should be hospitalized, that the patient should be fitted with an implantable therapy device configured to deliver therapy, and that therapy delivered to the patient should be modified.

15. A system comprising:

an implantable medical device (IMD) configured to obtain physiological parameters for a patient; and

an external computing device configured to;

receive the physiological parameters;

determine, from the physiological parameters, a first heart rate turbulence (HRT) slope at a first time and a second HRT slope at a second time;

calculate a difference value between the first slope and the second slope; and

determine a level of recovery of autonomic function based on the calculated difference.

16. The system of claim 15, wherein the first time is approximately one week after the occurrence of a myocardial infarction, and wherein the second time is approximately six weeks after the occurrence of a myocardial infarction.

17. The system of claim 15, wherein the external computing device is further configured to:

compare the difference value to a threshold value of about 2 milliseconds per R-R interval, and wherein the external computing device is further configured to determine a level of recovery is further configured to determine the level of recovery based on the comparison.

18. The system of claim 17, wherein the external computing device configured to determine the level of recovery of autonomic function based on the calculation is further configured to:

determine the level of recovery to be in a first category if the difference value is equal to or greater than the threshold value; and

determine the level of recovery to be in a second category if the difference value is less than the threshold value.

19. The system of claim 18, wherein the external computing device is further configured to:

generate a risk stratification indicator if the level of recovery is determined to be in the second category.

20. The system of claim 19, wherein the risk stratification indicator indicates at least one of that the patient should be hospitalized, that the patient should be fitted with an implantable therapy device configured to deliver therapy, and that therapy delivered to the patient should be modified.